Wikisage, the free encyclopedia of the second generation, is digital heritage

Zonisamide: Difference between revisions

From Wikisage
Jump to navigation Jump to search
mNo edit summary
Line 6: Line 6:
==LINK==
==LINK==


[https://www.ncbi.nlm.nih.gov/books/NBK1520/ MERFF]
[https://www.ncbi.nlm.nih.gov/books/NBK1520/ MERFF] : Myoclonic Epilepsy Associated with Ragged Red Fibers


[http://www.sciencedirect.com/science/article/pii/S0168010217301785?via%3Dihub Zonisamide inhibits monoaminooxidaseand enhances motor perfomance and social activity]
[http://www.sciencedirect.com/science/article/pii/S0168010217301785?via%3Dihub Zonisamide inhibits monoaminooxidase and enhances motor perfomance and social activity]


[https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5451432/ Efficacy and Tolerability of Second and Third Generation Anti-epileptic Drugs in Refractory Epilepsy: A Network Meta-Analysis]
[https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5451432/ Efficacy and Tolerability of Second and Third Generation Anti-epileptic Drugs in Refractory Epilepsy: A Network Meta-Analysis]


<references/>
<references/>
{{wikidata|Q219957}}
{{wikidata|Q219957}}

Revision as of 23:59, 25 August 2017

zonisamide is an 1,2-benzisoxazole-3-methanesulfonamide, that was initally used as anticonvulsant drug and latter as Parkinson-drug.

It inhibitory action against carbonic anhydrase coul be related with perception of taste, and the novo lipogenesis. [1]

LINK

MERFF : Myoclonic Epilepsy Associated with Ragged Red Fibers

Zonisamide inhibits monoaminooxidase and enhances motor perfomance and social activity

Efficacy and Tolerability of Second and Third Generation Anti-epileptic Drugs in Refractory Epilepsy: A Network Meta-Analysis

Q219957 at Wikidata  Interwiki via Wikidata